Krsnaa Diagnostics’ IPO garnered investor interest. Can it become the next Dr PathLabs, Thyrocare?

The diagnostics space has been seeing a lot of action since the Covid-19 outbreak. Shares of listed firms such as Dr Lal PathLabs, Metropolis Healthcare, and Thyrocare Technologies have surged between 160% and 200% so far since March 2020. There is now a greater realisation about the importance of diagnostics in preventing and managing diseases. This is a big positive for the industry, which is still largely fragmented and under-penetrated in